About A public-private partnership that supports the discovery of new medicines through open access research. Mission and Philosophy Partners Governance Collaborators Laboratories Key Achievements Strategic Alliances and Communications FAQs Sitemap Science TARGET ENABLING PACKAGES (TEPs) TISSUE PLATFORM PROTEIN STRUCTURES PUBLICATIONS CHEMICAL PROBES Donated chemical probes Biological probes Epigenetics Probes Collection Human Kinase Chemical Probe Program Probes against other protein classes RECOMBINANT ANTIBODIES Structure-guided Drug Discovery Coalition (SDDC) SDDC Publications CREATE ChemNET Research Program Trainees Open Access Learning Impact Faculty & Industry Participants Structural & Chemical Biology Bootcamp Events Structural Biology Programme Structural Parasitology Rare Diseases Genome Integrity and Neurodegeneration Growth Factor Signalling Integral Membrane Proteins Metabolic Enzymes Phosphorylation-Dependent Signalling Protein Kinases Ubiquitin Biology Chemical Biology Antibodies Protein Families Protein Methyltransferases Histone Deacetylases Histone Acetyltransferases Demethylases Bromodomains Methyl Lysine Readers Probe Development Screening Platforms Epigenetic Cell Assays Fragment Based Screening Informatics Medicinal Chemistry ChromoHub Phylogenetic Trees UbiHub Phylogenetic Trees Histone Tails Epigenetics Pocketome Technological Science Biotechnology Biophysics Screening Platforms Research Informatics Protein Crystallography Medicinal Chemistry Reagents & Resources Reagents Chemical Probes Antibodies SGC Vectors SGC Plasmids SGC Constructs Resources Structure Gallery Protein Production Protocols ChromoHub Phylogenetic Trees UbiHub Phylogenetic Trees Histone Tails Fragment Screening Crystal Forms Fragalysis MichaelaNGLo Technologies High Throughput Protein Crystallisation Lex Bubbling System Frapid People Global SGC Director Aled Edwards Susan McCormick Max Morgan Academic Collaborators Industrial/ SME collaborators Non-Scientists Toronto Cheryl Arrowsmith Dalia Barsyte-Lovejoy Peter J. Brown Jinrong Min Takis Prinos Matthieu Schapira Masoud Vedadi Levon Halabelian Biotechnology Crystallography Oxford Chas Bountra Paul Brennan Alex N. Bullock Nicola Burgess-Brown Liz Carpenter Jon Elkins Gillian Farnie Oleg Fedorov Panagis Filippakopoulos Opher Gileadi Kilian Huber Brian Marsden Udo Oppermann Frank von Delft Wyatt Yue UNICAMP Paulo Arruda Mario H. Bengtson Rafael M. Couñago Katlin B. Massirer UNC Tim Willson Bill Zuercher Carrow Wells Alison Axtman David Drewry Karolinska Michael Sundström Susanne Gräslund Louise Berg Per-Johan Jakobsson Frankfurt Stefan Knapp Susanne Müller-Knapp Alexandra Stolz Masato Akutsu News & Outreach News & Events SGC News Symposia & Workshops Blog Press Releases Public Events Public Engagement SGC Languages General Public Open Lab Notebooks Schools Media Patient Groups Governments TOronto Ubiquitin Club And Network (TOUCAN) Careers Tweets by thesgconline
A public-private partnership that supports the discovery of new medicines through open access research.
The SGC embarks on a new project as part of the EUbOPEN Consortium The consortium consists of 22 partners that will work together to develop high quality chemical tools
The SGC embarks on a new project as part of the EUbOPEN Consortium The consortium consists of 22 partners that will work together to develop high quality chemical tools
Rapidly Emerging Antiviral Drug Development Initiative (READDI) Open science drug discovery partnership, READDI, aims to invest $125 million to prevent future pandemics
Rapidly Emerging Antiviral Drug Development Initiative (READDI) Open science drug discovery partnership, READDI, aims to invest $125 million to prevent future pandemics
New Open-AD Drug Discovery Center SGC and collaborators to create open research tools for Alzheimer’s disease research funded by National Institute on Aging
New Open-AD Drug Discovery Center SGC and collaborators to create open research tools for Alzheimer’s disease research funded by National Institute on Aging
Discovery of a chemical probe for PRDM9 A collaboration between MSD and the SGC has resulted in the discovery of MRK-740, a potent inhibitor of PRDM9
Discovery of a chemical probe for PRDM9 A collaboration between MSD and the SGC has resulted in the discovery of MRK-740, a potent inhibitor of PRDM9
MTase Chemical Probe Toolbox A collection of well-characterized chemical probes and related reagents for the study of methylation-mediated signaling.
MTase Chemical Probe Toolbox A collection of well-characterized chemical probes and related reagents for the study of methylation-mediated signaling.